Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery

被引：0
|
作者：
Tong, Z. [1 ]
Fu, G. [2 ]
Zhou, F. [2 ]
Liu, X. [3 ]
Xue, X. [4 ]
Zhang, H. [1 ]
Wang, Y. [2 ]
Zhu, X. [1 ]
Gao, Y. [1 ]
Liu, L. [1 ]
Bao, X. [1 ]
Zheng, Y. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
Jin, B. [2 ]
机构：
[1] Zhejiang Univ, Dept Med Oncol, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou, Peoples R China
[3] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Dept Radiol, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2375P
引用
收藏
页码：S1210 / S1210
页数：1
相关论文
共 50 条
  • [21] Bladder-sparing trimodality approach for unfit for surgery and cisplatin treatment elderly patients with muscle-invasive bladder cancer (MIBC): results from a monocentric experience
    Rozzi, A.
    Nappa, M.
    Costa, A. M.
    Spigone, B.
    Falbo, P. T.
    Di Nicola, S.
    De Marco, F.
    Corona, M.
    Iannace, A.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study
    Luo, Cheng
    Luo, Shuhang
    Wusimanjiang, Wumier
    Wang, Zongren
    Liu, Ping
    Wang, Bin
    Yuan, Dan
    Lin, Hao
    Xu, Abai
    Deng, Nan
    Wu, Kaihui
    Zhu, Xuejin
    Xu, Peng
    Chen, Junxing
    Huang, Bin
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1759 - 1767
  • [23] Neoadjuvant Cohort Study in muscle-invasive Bladder Cancer (MIBC) before Cystectomy
    Rexer, Heidrun
    Boegemann, Martin
    Retz, Margitta
    AKTUELLE UROLOGIE, 2024, 55 (04) : 300 - 301
  • [24] Neoadjuvant cohort study in muscle-invasive bladder cancer (MIBC) before cystectomy
    不详
    UROLOGIE, 2024, 63 (07): : 746 - 747
  • [25] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Nezu, Masahiko
    Itoh, Kuniaki
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 310 - 317
  • [26] Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer
    Jiang, Di
    Jiang, Haiyan
    Chung, Peter W. M.
    Zlotta, Alexandre R.
    Fleshner, Neil Eric
    Bristow, Robert G.
    Berlin, Alejandro
    Kulkarni, Girish S.
    Alimohamed, Nimira S.
    Lo, Gregory
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : 38 - 45
  • [27] Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy (CRT) in muscle-invasive urothelial carcinoma of bladder (MIBC): A combined retrospective analysis of two prospective studies.
    Hong, Joohyun
    Choi, Daeho
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [28] Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle- invasive bladder cancer (MIBC): HCRN GU 16-257.
    Galsky, Matt D.
    Daneshmand, Siamak
    Chan, Kevin G.
    Dorff, Tanya B.
    Cetnar, Jeremy Paul
    Neil, Brock O.
    D'souza, Anishka
    Mamtani, Ronac
    Kyriakopoulos, Christos
    Garcia, Philip
    Izadmehr, Sudeh
    Yu, Menggang
    Zhao, Qianqian
    Mehrazin, Reza
    Lewis, Sara C.
    Sfakianos, John
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Co-primary endpoint analysis of HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle-invasive bladder cancer (MIBC).
    Galsky, Matt D.
    Daneshmand, Siamak
    Lewis, Sara C.
    Chan, Kevin G.
    Dorff, Tanya B.
    Cetnar, Jeremy Paul
    Mamtani, Ronac
    Kyriakopoulos, Christos
    Gogerly-Moragoda, Mahalya
    Izadmehr, Sudeh
    Yu, Menggang
    Zhao, Qianqian
    Jun, Tomi
    Mehrazin, Reza
    Sfakianos, John P.
    Pal, Sumanta Monty
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
12345